Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Submitted by
admin
on May 23, 2016 - 9:41pm
Source:
Yahoo/Reuters
News Tags:
Samsung Bioepis
Remicade
biosimilars
FDA
rheumatoid arthritis
JNJ
Headline:
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Do Not Allow Advertisers to Use My Personal information
